NCT04309123View on ClinicalTrials.gov

Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 30, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

April 1, 2021

Conditions
Ventilator-Induced Diaphragm Dysfunction
Interventions
DEVICE

TransAeris System

The TransAeris System is a temporary percutaneous intramuscular diaphragm stimulator intended for patients at risk of or on prolonged positive pressure mechanical ventilation. TransAeris is indicated for use in the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD).

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Cleveland

Sponsors

Lead Sponsor

Synapse Biomedical
All Listed Sponsors
lead

Synapse Biomedical

INDUSTRY

NCT04309123 - Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation | Biotech Hunter | Biotech Hunter